Skip to main content
. 2019 Apr;83(2):80–89.

Table IV.

Unconditional associations between herd management and antimicrobial use practices and antimicrobial resistance in at least 1 E. coli isolate from a composite fecal sample collected from 20 cows per herd at fall pregnancy testing (n = 96 herds).

Resistant to at least 1 antimicrobial Resistant to at least 2 antimicrobials Resistant to sulfisoxazole and streptomycin Intermediate or resistant to tetracycline




OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Sample collection date 0.11 0.35 0.44 0.11
November: Octobera 0.22 (0.02 to 1.5) 0.16 0.41 (0.03 to 3.9) 0.61 0.64 (0.04 to 9.5) 0.99 0.22 (0.02 to 1.5) 0.16
December: October 0.14 (0.003 to 1.4) 0.13 0.26 (0.005 to 3.6) 0.49 0.41 (0.01 to 8.1) 0.88 0.14 (0.003 to 1.4) 0.13
January and February: October 0.81 (0.06 to 6.2) 0.99 1.5 (0.11 to 15) 0.99 2.3 (0.14 to 36) 0.78 0.81 (0.06 to 6.2) 0.99
Samples collected after weaning 0.85 (0.17 to 5.5) 0.99 0.59 (0.11 to 4.1) 0.74 0.47 (0.07 to 3.4) 0.57 0.85 (0.17 to 5.5) 0.99
Producer age (years) 1.0 (0.96 to 1.1) 0.60 1.0 (0.95 to 1.1) 0.73 1.0 (0.95 to 1.1) 0.64 1.0 (0.96 to 1.1) 0.66
Produces purebred cattle for sale 1.5 (0.23 to 7.4) 0.82 0.46 (0.01 to 3.9) 0.82 0.54 (0.01 to 4.9) 0.99 1.5 (0.23 to 7.4) 0.82
Total cows calved 2014 > 300 0.22 (0.005 to 1.7) 0.23 0.29 (0.01 to 2.5) 0.44 0.35 (0.01 to 3.1) 0.59 0.52 (0.05 to 2.9) 0.68
Number of cows to calf in 2014 0.996 (0.989 to 1.000) 0.17 0.997 (0.989 to 1.001) 0.25 0.997 (0.988 to 1.001) 0.30 0.998 (0.992 to 1.001) 0.30
Calves retained after weaning 0.04 (0.06 to 3.7) 0.86 0.22 (0.005 to 1.8) 0.25 0.26 (0.01 to 2.3) 0.37 0.69 (0.11 to 3.3) 0.88
Feedlot operation 0.65 (0.00 to 4.6) 0.71 0.83 (0.0 to 6.2) 0.88 0.97 (0.0 to 7.3) 0.98 1.1 (0.02 to 9.9) 0.99
Calving started before March 2014 1.6 (0.34 to 7.5) 0.70 1.6 (0.27 to 9.1) 0.79 1.2 (0.16 to 7.3) 0.99 1.0 (0.20 to 4.7) 0.99
Calf mortality > 5% 3.8 (0.68 to 19) 0.14 5.8 (0.94 to 36) 0.06 7.8 (1.2 to 61) 0.03 2.2 (0.32 to 12) 0.49
Antimicrobials provided to cows in feed 2.9 (0.42 to 15) 0.32 2.1 (0.19 to 14) 0.66 0.97 (0.02 to 9.1) 0.99 4.9 (0.87 to 25) 0.07
Injectable antimicrobials used on cows 0.98 (0.13 to 8) 0.99 0.76 (0.10 to 8) 0.99 0.65 (0.08 to 8) 0.99 0.98 (0.13 to 8) 0.99
Highest % of cows in which antimicrobials were used for any reason 1.0 (0.99 to 1.0) 0.31 1.0 (0.97 to 1.0) 0.65 1.0 (0.94 to 1.0) 0.99 1.0 (1.0 to 1.1) 0.07
Antimicrobials used in cows
 Aminoglycosides (not topical) 8.6 (0.0 to 335) 0.99 11 (0.0 to 429) 0.99 13 (0.0 to 496) 0.99 8.6 (0.0 to 335) 0.99
 1st generation cephalosporins 2.2 (0.0 to 22) 0.99 2.9 (0.0 to 29) 0.99 3.3 (0.0 to 34) 0.99 2.2 (0.0 to 22) 0.99
 Ceftiofur 1.0 (0.0 to 7.9) 0.99 1.3 (0.0 to 10) 0.99 1.5 (0.0 to 12) 0.99 1.0 (0.0 to 7.9) 0.99
 Florfenicol 2.9 (0.60 to 14) 0.22 4.9 (0.87 to 34) 0.08 3.8 (0.59 to 28) 0.19 2.9 (0.60 to 14) 0.22
 Lasalocid 9.0 (0.11 to 750) 0.40 12 (0.14 to 986) 0.32 14 (0.16 to 1163) 0.29 9.0 (0.11 to 750) 0.40
 Macrolides 0.30 (0.0 to 2.0) 0.26 0.39 (0.0 to 2.7) 0.39 0.46 (0.0 to 3.3) 0.49 0.30 (0.0 to 2.0) 0.26
 Monensin 2.8 (0.24 to 19) 0.47 1.4 (0.03 to 14) 0.99 0.97 (0.0 to 7.3) 0.98 5.5 (0.74 to 34) 0.10
 Penicillin 1.9 (0.39 to 8.8) 0.54 1.1 (0.15 to 5.8) 0.99 1.3 (0.18 to 8.4) 0.99 2.9 (0.64 to 15) 0.20
 Polymyxinsb 0.46 (0.0 to 3.2) 0.49 0.6 (0.0 to 4.3) 0.66 0.69 (0.0 to 5.1) 0.76 0.46 (0.0 to 3.2) 0.49
 Sulfa boluses (including intra-uterine) 2.3 (0.04 to 26) 0.86 3.0 (0.05 to 36) 0.72 1.9 (0.0 to 16) 0.99 2.3 (0.04 to 26) 0.86
 Tetracyclines 0.6 (0.13 to 4.1) 0.76 0.43 (0.08 to 3.1) 0.48 0.34 (0.05 to 2.6) 0.35 0.62 (0.13 to 4.1) 0.76
 Trimethoprim-sulfadoxine 1.5 (0.03 to 15) 0.99 1.9 (0.04 to 20) 0.94 2.3 (0.04 to 25) 0.84 1.5 (0.03 to 14) 0.99
 Category-I drugs used in cow herdc 0.26 (0.0 to 1.8) 0.19 0.34 (0.0 to 2.4) 0.32 0.40 (0.0 to 3.8) 0.40 0.26 (0.0 to 1.8) 0.19
 Category-II drugs used in cow herdc 1.0 (0.21 to 4.7) 0.99 0.58 (0.08 to 3.2) 0.72 0.74 (0.10 to 4.6) 0.99 1.6 (0.34 to 8.1) 0.74
 Highest % of preweaned calf herd in which antimicrobials were used for any reason 1.0 (1.0 to 1.0) 0.10 1.0 (0.99 to 1.0) 0.22 1.0 (0.98 to 1.0) 0.54 1.0 (0.98 to 1.0) 0.41
a

Samples collected in November compared to the samples collected in October (reference category).

b

Contained in intra-mammary preparation (Special Formula 17900-Forte Suspension).

c

Importance to human health as categorized by Health Canada (15). Category I includes drugs of very high importance to human health and Category II is of high importance.

OR — odds ratio; CI — confidence interval.

Values in bold signify factors where P < 0.20.